COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Lexapro®'s Efficacy After Dose Escalation in Remission Study (LEADERS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01594866
Recruitment Status : Completed
First Posted : May 9, 2012
Last Update Posted : September 7, 2018
H. Lundbeck A/S
Information provided by (Responsible Party):
Yong Min Ahn, Seoul National University Hospital

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : June 2016
Actual Study Completion Date : December 2016